6 completed, 1 unknown. 3 Phase 3, 2 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Not applicable | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Biltricide: new trials by email Literature Review of Biltricide trials Research Report on Biltricide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni Ujiplus®, Praziquantel 400mg - Schistosoma Mansoni | Phase 2 / Phase 3 | Completed | Kenya Medical Research Institute | 400 | 2021-05-06 | 2022-07-12 |
| Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST) 4x Praziquantel, 1x Praziquantel - Schistosomiasis | Phase 3 | Completed | Leiden University Medical Center | 167 | 2018-10-01 | 2020-11-18 |
| Praziquantel Bioequivalence Study Cisticid, Biltricide - Healthy | Phase 1 | Completed | Merck KGaA, Darmstadt, Germany | 60 | 2018-06-18 | 2019-09-18 |
| Arachidonic Acid Treatment Against Schistosomiasis Infection in Children Praziquantel (PZQ), Arachidonic acid (ARA), PZQ+ARA - Schistosomiasis, Bilharzia | Not applicable | Completed | dsm-firmenich Switzerland AG | 335 | 2013-01-01 | 2014-05-22 |
| Prevention of Female Genital Schistosomiasis (FGS) in Rural High-endemic South Africa Praziquantel - Uro-genital Schistosomiasis | Unknown | Oslo University Hospital | 6500 | 2010-04-01 | 2017-09-19 | |
| A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni Artesunate+Sulfamethoxypyrazine/pyrimethamine, Praziquantel - Schistosoma Mansoni | Phase 3 | Completed | Kenya Medical Research Institute | 212 | 2009-10-01 | 2010-01-22 |
| Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar Treatment with anti-STI and anti-schistosoma regimens - Sexually Transmitted Infections, Schistosoma Haematobium | Not applicable | Completed | University of Aarhus | 680 | 2001-08-01 | 2008-07-14 |
Schistosomiasis (4) · Sexually Transmitted Diseases (2) · Schistosomiasis haematobia (1)
Kenya Medical Research Institute (2) · Leiden University Medical Center (1) · Merck KGaA, Darmstadt, Germany (1) · Oslo University Hospital (1) · University of Aarhus (1) · dsm-firmenich Switzerland AG (1)
Kenya (2) · Côte d’Ivoire (1) · Egypt (1) · Madagascar (1) · Mexico (1) · South Africa (1)
Elijah M Songok, PhD (1) · Eyrun F Kjetland, MD, PhD (1) · Jane Kvalsvig, PhD (1) · Jean Coulibaly (1) · Myra Taylor, PhD (1) · Pauline N Mwinzi, PhD (1) · Peter DC Leutscher, MD, PhD (1) · Rashida Barakat, Ph.D. (1) · Rashika El Ridi (1) · Sahar Selim, Ph.D. (1) · Svein G Gundersen, MD, PhD (1)
PMID 20705516, PMID 23556009, PMID 24470560, PMID 24896815, PMID 25179171, PMID 25281761, PMID 25412334, PMID 25623258, PMID 25624403, PMID 25630808, PMID 25768005, PMID 25918212, PMID 27073857, PMID 27168759, PMID 27854250, PMID 29801483, PMID 32196506, PMID 36548444
2016 (1)